What Europeans Are Doing to Limit Migraine Frequency
By Russell Martin
Relief for Respiratory, Gastrointestinal Conditions
The ability of butterbur’s active ingredient petasin to quell smooth muscle spasms in vascular walls (which may contribute to migraine) allows it to similarly benefit other parts of the body, thereby mitigating disorders unrelated to migraine.2,30
In Europe, butterbur extract is commonly used to battle allergic rhinitis (hay fever), and studies have confirmed its efficacy, both compared to a commonly used prescription medication and in a double- blind, placebo-controlled study. When butterbur extract was compared with Zyrtec®, the brand name of the anti-allergy prescription medication cetirizine, researchers determined that both compounds were equally effective in limiting sneezing, nasal congestion, runny nose, itchy nose, and itchy eyes. Among the 131 patients studied over two weeks, half took butterbur extract to relieve their symptoms and the other half took cetirizine. The researchers believe that petasin in butterbur extract proved efficacious by limiting histamine and leukotriene, which promote inflammation and mucous secretions, and by dilating constricted airways to ease breathing.30
Butterbur leaves and root have been used for centuries to manage bronchial asthma and whooping cough. A recent Scottish study showed that the anti-inflammatory action of 25 mg of butterbur extract taken twice daily significantly improved out-breath volume in asthma patients who regularly treat their symptoms with inhaled corticosteroids. The investigators noted that butterbur complemented the activity of the corticosteroids and showed a superior effect compared to placebo.31
Furthermore, in a German open trial, 80 asthma sufferers who took 50 mg of butterbur extract three times a day saw the number, duration, and severity of their asthma attacks decrease during an eight-week study period. The study authors speculated that butterbur extract may be effective both as a stand-alone asthma treatment and in combination with other asthma medications.32
Historically, butterbur has been used as a folk medicine for various gastrointestinal disorders, particularly digestive tract spasms associated with colic and bile flow obstruction. A contemporary German study found butterbur extract can block ethanol-induced damage to the stomach and reduce ulcerations in the small intestine.33 German researchers are studying butterbur’s potential applications in controlling spasms of the urogenital tract, which can contribute to urinary urgency and incontinence. They believe that butterbur may prove effective in managing these disorders.34
As more and more research documenting butterbur’s ability to reduce migraine attacks comes to light, thousands of sufferers are turning to this herbal extract as a safe, effective, and natural way to limit the crippling effects of migraine headaches.
Since its clinical use began in Germany in 1985, nearly half a million people have been treated with standardized butterbur extract, with significant success and virtually no side effects.13 Investigators in Europe and North America are testing butterbur’s applications in managing various disorders like hay fever, gastrointestinal conditions, and urogenital disorders. Butterbur thus appears to be a promising natural remedy for many common health complaints.
1. Lipton RB, Gobel H, Einhaupl KM, Wilks K, Mauskop A. Petasites hybridus root (butterbur) is an effective preventive treatment for migraine. Neurology. 2004 Dec 28;63(12):2240-4.
2. Anon. Monograph. Petasites hybridus. Altern Med Rev. 2001 Apr;6(2):207-9.
3. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA. 1992 Jan 1;267(1):64-9.
4. Wenzel RG, Sarvis CA, Krause ML. Over-the-counter drugs for acute migraine attacks: literature review and recommendations. Pharmacotherapy. 2003 Apr;23(4):494-505.
5. Available at: www.nutraceuticalsworld.com. Accessed December 16, 2005.
6. Welch KM. Pathogenesis of migraine. Semin Neurol. 1997;17(4):335-41.
7. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgia and facial pain. Cephalalgia. 1988;8(Suppl 7):1-96.
8. Goadsby PJ, Lipton RB, Ferrari MD. Migraine—current understanding and treatment. N Engl J Med. 2002 Jan 24;346(4):257-70.
9. Available at: http://www.migraineaid.com/studies/1996-03-05FreieArtz/. Accessed December 16, 2005.
10. Grossmann M, Schmidramsl H. An extract of Petasites hybridus is effective in the prophylaxis of migraine. Int J Clin Pharmacol Ther. 2000 Sep;38(9):430-5.
11. Available at: http://www.wchstv.com/newsroom/healthyforlife/23.63.shtml. Accessed December 16, 2005.
12. Pothmann R, Danesch U. Migraine prevention in children and adolescents: results of an open study with a special butterbur root extract. Headache. 2005 Mar;45(3):196-203.
13. Danesch U, Rittinghausen R. Safety of a patented special butterbur root extract for migraine prevention. Headache. 2003 Jan;43(1):76-8.
14. Phillips S, Ruggier R, Hutchinson SE. Zingiber officinale (ginger)—an antiemetic for day case surgery. Anaesthesia. 1993 Aug;48(8):715-7.
15. Mowrey DB, Clayson DE. Motion sickness, ginger, and psychophysics. Lancet. 1982 Mar 20;1(8273)655-7.
16 Grontved A, Brask T, Kambskard J, Hentzer E. Ginger root against seasickness: A controlled trial on the open sea. Acta Otolaryngol. 1988 Jan-Feb;105(1-2):45-9.
17. Keating A, Chez RA. Ginger syrup as an antiemetic in early pregnancy. Altern Ther Health Med. 2002 Sep-Oct;8(5):89-91.
18. Japan Centra Revuo Medicina.1954:12;669.
19. Zhou JG. Tianjin Medical Journal. 1960, 2:131.
20. Ghazanfar SA. Handbook of Arabian Medicinal Plants. Boca Raton, FL: CRC Press; 1990.
21. Kowa H, Takeshima T, Nakashima K. Migraine update. Nippon Rinsho. 2005 Oct;63(10):1733-41.
22. Mascolo N, Jain R, Jain SC, Capasso F. Ethnopharmacologic investigation of ginger (Zingiber officinale). J Ethnopharmacology. 1989 Nov;27(1-2):129-40.
23. Flynn DL, Rafferty MF, Boctor AM. Inhibition of human neutrophil 5-lipoxygenase activity by gingerdione, shogaol, capsaicin and related pungent compounds. Prostaglandins Leukotrienes Med. 1986 Oct;24(2-3):195-8.
24. Kiuchi F, Shibuya M, Sankawa U. Inhibitors of prostaglandin biosynthesis from ginger. Chem Pharm Bull. 1982 Feb;30(2):754-7.
25. Sheftell F, Rapoport A, Weeks R, Walker B, Gammerman I, Baskin S. Montelukast in the prophylaxis of migraine: a potential role for leukotriene modifiers. Headache. 2000 Feb;40(2):158-63.
26. Grzanna R, Lindmark L, Frondoza CG. Ginger—an herbal medicinal product with broad anti-inflammatory actions. J Med Food. 2005 Summer;8(2):125-32.
27. Ishizaki K, Takeshima T, Fukuhara Y, et al. Increased plasma transforming growth factor-beta-1 in migraine. Headache. 2005 Oct;45(9):1224-8.
28. Vishwakarma SL, Pal SC, Kasture VS, Kasture SB. Anxiolytic and antiemetic activity of Zingiber officianale. Phytother Res. 2002 Nov;16(7):621-6.
29. Lanteri-Minet M, Radat F, Chautard MH, Lucas C. Anxiety and depression associated with migraine: Influence on migraine subjects’s disability and quality of life, and acute migraine management. Pain. 2005 Dec 5;118(3):319-26.
30. Available at: http://www.herbalgram.org/herbalgram/articleview.asp?a=2707. Accessed December 16, 2005.
31. Lee DK, Haggart K, Robb FM, Lipworth BJ. Butterbur, a herbal remedy, confers complementary anti-inflammatory activity in asthmatic patients receiving inhaled corticosteroids. Clin Exp Allergy. 2004 Jan;34(1):110-14.
32. Danesch UC. Petasites hybridus (Butterbur root) extract in the treatment of asthma—an open trial. Altern Med Rev. 2004 Mar;9(1):54-62.
33. Brune K, Bickel D, Peskar BA. Gastro-protective effects by extracts of Petasites hybridus: the role of inhibition of peptido-leukotriene synthesis. Planta Med. 1993 Dec;59(6):494-6.
34. Kalin P. The common butterbur (Petasites hybridus)—portrait of a medicinal herb. Forsch Komplementarmed Klass Naturheilkd. 2003 Apr;10 Suppl 141-44.
35. Schoenen J, Lenaerts M, Bastings E. High-dose riboflavin as a prophylactic treatment of migraine: results of an open pilot study. Cephalalgia. 1994 Oct;14(5):328-9.
36. Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology. 1998 Feb;50(2):466-70.
37. Boehnke C, Reuter U, Flach U, Schuh-Hofer S, Einhaupl KM, Arnold G. High-dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre. Eur J Neurol. 2004 Jul;11(7):475-7.
38. Maizels M, Blumenfeld A, Burchette R. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache. 2004 Oct;44(9):885-90.